Article
Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Apr 2009
O'Reilly Kathryn E, Warycha Melanie, Davies Michael A, Rodrik Vanessa, Zhou Xi K, Yee Herman, Polsky David, Pavlick Anna C, Rosen Neal, Bhardwaj Nina, Mills Gordon, Osman Iman
Abstract excerpt
PURPOSE: Both phosphatidylinositol 3-kinase/AKT and RAS/mitogen-activated protein kinase signal transduction pathways mediate 4E-BP1 phosphorylation, releasing 4E-BP1 from the mRNA cap and permitting translation initiation. Given the prevalence of PTEN and BRAF mutations in melanoma, we first examined translation initiation, as measured by phosphorylated 4E-BP1 (p-4E-BP1), in metastatic melanoma tissues and cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
